MarketCap
Facebook
X
Telegram
Ampio Pharmaceuticals Kurzfristige Verbindlichkeiten | AMPE
Kurzfristige Verbindlichkeiten Jährlich Ampio Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.38 M | 1.19 M | 5.12 M | 1.83 M | 4.28 M | 1.38 M | 3.88 M | 2.13 M | 5.52 M | 3.68 M | 2.47 M | 1.64 M | 1.29 M | 4.75 M | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.52 M | 1.19 M | 2.97 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Brickell Biotech
BBI
|
1.66 M | - | -5.38 % | $ 6.06 M |  USA |
 |
Applied Therapeutics
APLT
|
27.3 M | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
3.3 M | - | - | $ 8.86 M |  Canada |
 |
Generation Bio Co.
GBIO
|
35.1 M | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
4.79 M | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
87.1 M | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
48.4 M | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
42.6 M | $ 4.2 | -0.71 % | $ 651 M | USA |
 |
AbbVie
ABBV
|
43.3 B | $ 293.87 | 0.19 % | $ 520 B | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
1.47 B | $ 151.6 | -3.2 % | $ 19.9 B | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
2.84 M | $ 4.63 | 21.05 % | $ 20 M |  Israel |
 |
Avenue Therapeutics
ATXI
|
1.1 M | - | -52.27 % | $ 4.45 M | USA |
 |
Axon Enterprise
AXON
|
1.47 B | $ 302.6 | -0.19 % | $ 23.6 B | USA |
 |
Liquidia Corporation
LQDA
|
136 M | $ 51.37 | 7.31 % | $ 4.42 B | USA |
 |
CRISPR Therapeutics AG
CRSP
|
149 M | $ 45.05 | -9.97 % | $ 4.05 B |  Schweiz |
 |
Scholar Rock Holding Corporation
SRRK
|
55.4 M | $ 48.48 | -5.96 % | $ 5.56 B | USA |
 |
Geron Corporation
GERN
|
112 M | $ 0.96 | -3.71 % | $ 640 M | USA |
 |
Bristol-Myers Squibb Company
BMY
|
23.4 B | $ 62.8 | 1.06 % | $ 128 B | USA |
 |
Titan Pharmaceuticals
TTNP
|
483 K | - | -3.76 % | $ 3.47 M | USA |
 |
Celldex Therapeutics
CLDX
|
51 M | $ 30.68 | -1.81 % | $ 2.04 B | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
2.67 M | $ 4.0 | -6.76 % | $ 48.8 M | Israel |
 |
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
37.4 M | $ 317.26 | 0.99 % | $ 6.14 B | USA |
 |
Eli Lilly and Company
LLY
|
35.2 B | $ 1 432.7 | 1.47 % | $ 1.29 T | USA |
 |
TCR2 Therapeutics
TCRR
|
64.1 M | - | - | $ 58.1 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
85.1 M | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
TFF Pharmaceuticals
TFFP
|
2.43 M | - | -60.05 % | $ 125 K | USA |
 |
CorMedix
CRMD
|
174 M | $ 5.37 | -2.1 % | $ 387 K | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
64.5 M | - | -15.15 % | $ 60.3 M |  Britain |
 |
MannKind Corporation
MNKD
|
171 M | $ 4.22 | 0.84 % | $ 1.29 B | USA |
 |
AVEO Pharmaceuticals
AVEO
|
18.7 M | - | - | $ 521 M | USA |
 |
MediciNova
MNOV
|
3.8 M | $ 1.4 | -4.76 % | $ 68.7 M | USA |
 |
Merck & Co.
MRK
|
28.3 B | $ 147.75 | -0.68 % | $ 370 B | USA |
 |
Moderna
MRNA
|
1.99 B | $ 250.79 | -6.77 % | $ 97.6 B | USA |
 |
Axcella Health
AXLA
|
14.1 M | - | -16.42 % | $ 249 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
78.6 M | - | - | $ 2.02 B | USA |
 |
Intellia Therapeutics
NTLA
|
104 M | $ 11.18 | -7.72 % | $ 1.21 B | USA |
 |
Omeros Corporation
OMER
|
78.1 M | $ 17.3 | -1.48 % | $ 1.1 B | USA |
 |
Oramed Pharmaceuticals
ORMP
|
19.1 M | $ 3.97 | -0.75 % | $ 164 M | Israel |
 |
Tyme Technologies
TYME
|
7.39 M | - | 8.07 % | $ 54 M | USA |
 |
Puma Biotechnology
PBYI
|
81.3 M | $ 8.13 | -3.22 % | $ 407 M | USA |
 |
PDS Biotechnology Corporation
PDSB
|
9.48 M | $ 1.02 | -5.09 % | $ 47.3 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
1.71 M | $ 34.99 | 3.77 % | $ 147 M | USA |
 |
Pfizer
PFE
|
37 B | $ 29.34 | 0.36 % | $ 167 B | USA |
 |
Завод ДИОД
DIOD
|
105 M | - | - | - |  Russia |
 |
PainReform Ltd.
PRFX
|
2.44 M | $ 0.78 | -4.24 % | $ 505 K | Israel |